MedTrace Logo

Identifying Biological Markers for Severe Depression

NCT01831882 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 210

Last updated 2020-08-21

No results posted yet for this study

Summary

The primary objective of this study is to investigate the biological components of major depression. The investigators are particularity interested in genetic variation and how it contributes to cortisol (because cortisol is higher in severe depression than mild depression or healthy controls) and how it contributes to clinical symptoms, especially suicidal ideation/behavior and psychosis.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Alan Schatzberg, M.D. · Stanford University

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2020-08-31
Completion
2020-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01831882 on ClinicalTrials.gov